Filters
reset allOther countries
Results: 1 to 10 of 10
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Hereditary Thyroid Cancer - RET Gene Analysis GeneKor MSA Greece | 4 | 1 |
|
Sequencing of risk exons of the RET proto-oncogene (exons 8, 10, 11, 13, 14, 15, 16) Department of Molecular Endocrinology Institute of Endocrinology Czech Republic | 5 | 1 |
|
Baylor Genetics United States | 1 | 1 |
|
RET Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 (MEN2) Laboratorio de Genetica Clinica SL Spain | 2 | 1 |
|
Multiple Endocrine Neoplasia Type 2A, Sequencing Exons (10,11) RET Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Comprehensive Hereditary Cancer Panel Baylor Genetics United States | 132 | 61 |
|
Hereditary Endocrine Cancer Panel Baylor Genetics United States | 51 | 15 |
|
Hereditary Paraganglioma/Pheochromocytoma Panel Baylor Genetics United States | 21 | 9 |
|
Multiple endocrine neoplasia (MEN) 2A/FMTC (screening RET proto-oncogene) Molecular Diagnosis Centre National University Hospital Singapore | 1 | 1 |
|
Results: 1 to 10 of 10
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.